new molecules and indications for glp-1 medicines Emerging Frontiers in Therapeutics: A Comprehensive Evidence Base (2025) The Multifaceted Nature of GLP-1:

A recent meta-analysis involving 32,884 patients from 19 randomized controlled trials further confirmed a 23% reduction in all-cause mortality associated with GLP-1RAs use (OR = 0.77) (Rivera et al., 2024)

Frequently Asked Questions (FAQs) 1

Studies with treatment with GLP-1 analogues in type 2 diabetes have found that the initial postprandial insulin is increased after treatment, and this has been misinterpreted as evidence for a GLP-1 mediated insulin stimulation [28]

Timing considerations when switching medications If you are switching from semaglutide to tirzepatide or going the other direction , timing the transition correctly matters

If you already have diabetic retinopathy, diabetic macular edema, recent visual symptoms, or recent retinal treatment, ask for coordinated care between your diabetes doctor and your eye doctor before and during treatment